Interview with Dr. Jennifer Doudna

Interview with Dr. Jennifer Doudna

Extremely interesting interview with Dr. Jennifer Doudna, co-developer of the groundbreaking gene editing technology and Nobel Prizer winner in Chemistry this year together with Dr. Emmanuelle Charpentier. During this interview, Dr. Doudna talks in a very clear way...
Calyxha’s novel therapies

Calyxha’s novel therapies

Calyxha Biotechnologies GmbH is developing novel therapies targeting #neurodegeneration, the underlying cause of major human diseases, such as Parkinson’s disease. https://www.calyxha.com/